BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27861221)

  • 1. Clinical, Electrophysiology, and Pathology Features of Dynamin Centronuclear Myopathy: A Case Report and Review of Literature.
    Verma S; Balasubramanian SB
    J Clin Neuromuscul Dis; 2016 Dec; 18(2):84-88. PubMed ID: 27861221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
    Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
    Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
    Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
    Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel dynamin-2 gene mutation associated with a late-onset centronuclear myopathy with necklace fibres.
    Casar-Borota O; Jacobsson J; Libelius R; Oldfors CH; Malfatti E; Romero NB; Oldfors A
    Neuromuscul Disord; 2015 Apr; 25(4):345-8. PubMed ID: 25633151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.
    Bitoun M; Bevilacqua JA; Prudhon B; Maugenre S; Taratuto AL; Monges S; Lubieniecki F; Cances C; Uro-Coste E; Mayer M; Fardeau M; Romero NB; Guicheney P
    Ann Neurol; 2007 Dec; 62(6):666-70. PubMed ID: 17932957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
    Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
    Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
    Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
    J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China.
    Chen T; Pu C; Wang Q; Liu J; Mao Y; Shi Q
    Neurol Sci; 2015 May; 36(5):735-41. PubMed ID: 25501959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
    Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
    Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
    Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
    Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult centronuclear myopathies: A hospital-based study.
    Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
    Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.
    Susman RD; Quijano-Roy S; Yang N; Webster R; Clarke NF; Dowling J; Kennerson M; Nicholson G; Biancalana V; Ilkovski B; Flanigan KM; Arbuckle S; Malladi C; Robinson P; Vucic S; Mayer M; Romero NB; Urtizberea JA; García-Bragado F; Guicheney P; Bitoun M; Carlier RY; North KN
    Neuromuscul Disord; 2010 Apr; 20(4):229-37. PubMed ID: 20227276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
    Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
    J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.
    Liewluck T; Lovell TL; Bite AV; Engel AG
    Neuromuscul Disord; 2010 Dec; 20(12):801-4. PubMed ID: 20817456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy.
    Biancalana V; Romero NB; Thuestad IJ; Ignatius J; Kataja J; Gardberg M; Héron D; Malfatti E; Oldfors A; Laporte J
    Acta Neuropathol Commun; 2018 Sep; 6(1):93. PubMed ID: 30208955
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
    Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
    Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, pathological and genetic characteristics of autosomal dominant inherited dynamin 2 centronuclear myopathy.
    Liu X; Wu H; Gong J; Wang T; Yan C
    Mol Med Rep; 2016 May; 13(5):4273-8. PubMed ID: 27035234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coexistence of dynamin 2 mutation and multiple mitochondrial DNA (mtDNA) deletions in the background of severe cardiomyopathy and centronuclear myopathy.
    Gal A; Inczedy-Farkas G; Pal E; Remenyi V; Bereznai B; Geller L; Szelid Z; Merkely B; Molnar MJ
    Clin Neuropathol; 2015; 34(2):89-95. PubMed ID: 25492887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic changes in the extraocular muscle in centronuclear myopathy with a Dynamin 2 mutation.
    Hanna N; Bouhenni R; Gupta B; Abu-Amero KK; Wollmann R; Edward DP
    Ophthalmic Genet; 2013; 34(1-2):83-6. PubMed ID: 22924779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
    Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
    Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.